Evidence map›Paper›PMID 39015826›Full record

ArticleCase reports in neurology

Severe Relapsing Autoimmune Encephalitis with GABA

Mélissa Boisclair, Charlotte Robitaille, Adrian Budhram, Amy Kunchok, Hugo Chapdelaine, Laurent Létourneau-Guillon, Gabrielle Macaron, Catherine Larochelle

Abstract readCase Reports
In one paragraph

Article in Case reports in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mélissa BoisclairDepartment of Neurosciences, Centre Hospitalier de l'Université de Montréal (CHUM), Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.
Charlotte RobitailleDepartment of Neurosciences, Centre Hospitalier de l'Université de Montréal (CHUM), Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.
Adrian BudhramDepartment of Clinical Neurological Sciences, London Health Sciences Centre, Western University, London, ON, Canada.
Amy KunchokMellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH, USA.
Hugo ChapdelaineDepartment of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.
Laurent Létourneau-GuillonDepartment of Radiology, Centre Hospitalier de l'Université de Montréal (CHUM), Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.
Gabrielle MacaronDepartment of Neurosciences, Centre Hospitalier de l'Université de Montréal (CHUM), Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.
Catherine LarochelleDepartment of Neurosciences, Centre Hospitalier de l'Université de Montréal (CHUM), Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: We report a challenging case of autoimmune encephalitis in a patient with a thymoma harboring titin and acetylcholine receptor antibodies, who experienced multiple relapses despite thymectomy and aggressive first-line immunotherapy, and for whom GABA Case Presentation: This 40-year-old man presented with headaches, weakness, diplopia, hearing loss, and seizures progressing to status epilepticus. Brain MRI showed multifocal cortical and subcortical T2/fluid attenuated inversion recovery hyperintense lesions without enhancement. Initial neural antibody testing identified only acetylcholine receptor and titin antibodies. He presented multiple severe relapses despite complete thymoma resection, intravenous methylprednisolone with immunoglobulins or plasmapheresis, and mycophenolate mofetil. Second-line immunotherapy with rituximab was successful to alleviate symptoms and normalize the EEG and MRI after identification of anti-GABA Conclusion: This case demonstrates the complexity and importance of identifying pathogenic antibodies and selecting 2nd line treatment accordingly in patients with autoimmune encephalitis when multiple antibodies coexist. Despite tumor resection, aggressive immunotherapy may be needed to prevent further deterioration in anti-GABA

Indexed as

Autoimmune encephalitisCase reportGABAA receptor antibodiesThymoma

Identifiers

PMID39015826
PMCPMC11250063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.